Leerink Starts Attovia Therapeutics (ATTO) at Outperform Aug 31, 2026 06:29AM
LifeSci Capital Starts Attovia Therapeutics (ATTO) at Outperform Aug 31, 2026 06:18AM
Citi Starts Attovia Therapeutics (ATTO) at Buy Aug 31, 2026 02:48AM
RBC Capital Starts Attovia Therapeutics (ATTO) at Outperform Aug 31, 2026 02:35AM
Morgan Stanley Starts Attovia Therapeutics (ATTO) at Overweight Aug 31, 2026 02:03AM


Aug 6, 2026 05:59AM Attovia Therapeutics lists on Nasdaq at $17 per share
Aug 5, 2026 10:56AM Attovia Therapeutics now indicated to open at $24, far above IPO price of $17
Aug 5, 2026 10:34AM Attovia Therapeutics indicated to open at $27, far above IPO price of $17
Jul 14, 2026 04:37PM Attovia Therapeutics files for IPO on Nasdaq